ArticleGenome biology2026
Determinants of mutation susceptibility along the genome are largely invariant across human tissues.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determinants of mutation susceptibility along the genome are largely invariant across human tissues.Genome biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe propensity for accumulating somatic mutations varies along the genome, which critically influences somatic mosaicism, tumor evolution and the potential role of somatic mutations in the context of age-associated diseases. Genomic factors contributing to the variability of mutation rates have been established, including, for example, distance from the replication origin, chromatin structure and sequence context. However, their relative importance for explaining variable mutation rates along the genome as well as variable mutation rates between tissues remains elusive.
resultsHere, we present a modelling strategy that integrates 146 genomic features at different scales to predict susceptibilities for point mutations in 25 human tissues along the genome. These models faithfully predict mutation rates in coding and non-coding parts of the human genome in cancer and healthy tissues, including even unseen tissue types that were not used during the model training. Our work revealed that the dependency of mutation rates on chromatin structure and other genomic features is remarkably invariant across tissues, pointing to fundamental, conserved processes underlying mutagenic processes. Local variability in mutation rates on the scale of a few base pairs is almost exclusively driven by the sequence context, whereas large-scale variability is dominated by chromatin features, gene expression and GC content.
conclusionsOur modelling strategy quantifies the relative contribution of genomic factors to mutation susceptibility, predicting mutational biases at any genomic resolution across human tissues, and provides a basis for better understanding tumor evolution and age-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.